Werkgroep Cardiologische centra Nederland English

ATHENA (Klaar)

A placebo- controlled, double- blind, parallel trial to access the efficacy of dronedarone 400 milligram 2x daags (b.i.d.) for the prevention of cardiovascular hospitalisation or death from any course, in patients with atrialfibrillation/ atrialflutter. (AF/ AFL)

Middel
dronedarone
Populatie
boezemfibrilleren
Fase
III
Jaar aanvang
2005
Meer informatie
ClinicalTrials.gov